ArticleHaematologica2017
Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases.
Open access · goldAbstract read
In one paragraph
Article in Haematologica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
4.5field-weighted citation impact, top 5% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 58 citations in OpenAlex.
- Medical and Non-medical Costs of Sickle Cell Disease and Treatments from a US Perspective: A Systematic Review and Landscape Analysis.PharmacoEconomics - open · 2022Pooled it
- American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation.Blood advances · 2021Guideline
- Outcomes of hematopoietic stem cell transplantation in adult sickle cell disease patients: A Single-Center experience from India.Annals of hematology · 2026Article
- Curative Approach to the Treatment of Beta-Thalassemia and Sickle Cell Disease with Hematopoietic Stem Cell Transplantation.Journal of clinical medicine · 2026Review
- Is allogeneic transplantation for sickle cell disease still relevant in the era of gene therapy?Blood advances · 2025Review
- A review on disease modifying pharmacologic therapies for sickle cell disease.Annals of hematology · 2025Review
- Late effects of hemopoietic stem cell transplant for sickle cell disease: monitoring and management.Expert review of hematology · 2024Review
- A budget impact analysis of gene therapy for sickle cell disease: an updated analysis.Blood advances · 2024Article
- The effectiveness of hematopoietic stem cell transplantation in treating pediatric sickle cell disease: Systematic review and meta-analysis.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024Review
- A landscape analysis and discussion of value of gene therapies for sickle cell disease.Expert review of pharmacoeconomics & outcomes research · 2022Article
- Debating the Future of Sickle Cell Disease Curative Therapy: Haploidentical Hematopoietic Stem Cell Transplantation vs. Gene Therapy.Journal of clinical medicine · 2022Article
- Fertility preservation for pediatric patients with hemoglobinopathies: Multidisciplinary counseling needed to optimize outcomes.Frontiers in endocrinology · 2022Review
- Evidence-Based Minireview: In young children with severe sickle cell disease, do the benefits of HLA-identical sibling donor HCT outweigh the risks?Hematology. American Society of Hematology. Education Program · 2021Review
- Hematopoietic Cell Transplantation Outcomes among Medicaid and Privately Insured Patients with Sickle Cell Disease.Transplantation and cellular therapy · 2021Article
- Broad-Spectrum Antibiotics and Risk of Graft-versus-Host Disease in Pediatric Patients Undergoing Transplantation for Acute Leukemia: Association of Carbapenem Use with the Risk of Acute Graft-versus-Host DiseaseTransplantation and cellular therapy · 2021Article
- The Impact of Donor Type on Outcomes and Cost of Allogeneic Hematopoietic Cell Transplantation for Pediatric Leukemia: A Merged Center for International Blood and Marrow Transplant Research and Pediatric Health Information System Analysis.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2020Article
- Comparison of US Federal and Foundation Funding of Research for Sickle Cell Disease and Cystic Fibrosis and Factors Associated With Research Productivity.JAMA network open · 2020Article
- Improved health care utilization and costs in transplanted versus non-transplanted adults with sickle cell disease.PloS one · 2020Article
- Hematopoietic Cell Transplantation for Sickle Cell Disease.Frontiers in pediatrics · 2020Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
45 authors at 20 institutions in 8 countries.
Staci D ArnoldEmory University Hospital, Atlanta, GA, USA.
Ruta BrazauskasCIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Naya HeCIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Yimei LiUniversity of Pennsylvania, Philadelphia, PA, USA.
Richard AplencUniversity of Pennsylvania, Philadelphia, PA, USA.
Zhezhen JinDepartment of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, USA.
Matt HallDivision of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, Columbia University Medical Center, New York, NY, USA.
Yoshiko AtsutaJapanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
Jignesh DalalRainbow Babies & Children's Hospital, Cleveland, OH, USA.
Theresa HahnDepartment of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA.
Nandita KheraDepartment of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA.
Carmem BonfimHospital de Clinicas-Federal University of Parana, Curitiba, Brazil.
Navneet S MajhailBlood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
Miguel Angel DiazDepartment of Hematology/Oncology, Hospital Infantil Universitario Nino Jesus, Madrid, Spain.
Cesar O FreytesTexas Transplant Institute, San Antonio, TX, USA.
William A WoodDivision of Hematology/Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.
Bipin N SavaniDivision of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Rammurti T KambleDivsion of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA.
Susan ParsonsTufts Medical Center, Boston, MA, USA.
Ibrahim AhmedRainbow Babies & Children's Hospital, Cleveland, OH, USA.
Keith SullivanDuke University Medical Center, Durham, NC, USA.
Sara BeattieUniversity of Ottawa, Canada.
Christopher DandoyCincinnati Children's Hospital Medical Center, OH, USA.
Reinhold MunkerSection of Hematology/Oncology, Department of Internal Medicine, Louisiana State University Health Shreveport, LA, USA.
Susana MarinoUniversity of Chicago Hospitals, Chicago, IL, USA.
Menachem BitanDepartment of Pediatric Hematology/Oncology, Tel-Aviv Sourasky Medical Center, Israel.
Hisham Abdel-AzimDivision of Hematology, Oncology and Blood & Marrow Transplantation, Children's Hospital of Los Angeles, University of Southern California Keck School of Medicine, CA, USA.
Mahmoud AljurfDepartment of Oncology, King Faisal Specialist Hospital Center & Research, Riydah, Saudi Arabia.
Richard F OlssonDivision of Therapeutic Immunology, Department of Laboratory Medicine, Karolinksa Institutet, Stockholm, Sweden.
Sarita JoshiPediatric Hematology, Oncology and BMT, Nationwide Children's Hospital and Ohio State University Wexner, Columbus, OH, USA.
Dave BuchbinderDivision of Pediatrics Hematology, Children's Hospital of Orange County, Orange, CA, USA.
Michael J EckrichLevine Children's Hospital, Charlotte, NC, USA.
Shahrukh HashmiDepartment of Oncology, King Faisal Specialist Hospital Center & Research, Riydah, Saudi Arabia.
Hillard LazarusSeidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH, USA.
David I MarksAdult Bone Marrow Transplant, University Hospitals Bristol NHS Trust, Bristol, United Kingdom.
Amir SteinbergDepartment of Hematology-Oncology, Mount Saini Hospital, New York, NY, USA.
Ayman SaadDivision of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Usama GergisHematologic Malignancies & Bone Marrow Transplant, Department of Medical Oncology, New York Presbyterian Hospital/Weill Cornell Medical College, New York, NY, USA.
Lakshmanan KrishnamurtiEmory University Hospital, Atlanta, GA, USA.
Allistair AbrahamDivision of Blood and Marrow Transplantation, Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, DC, USA.
Hemalatha G RangarajanPediatric Hematology, Oncology and BMT, Nationwide Children's Hospital and Ohio State University Wexner, Columbus, OH, USA.
Mark WaltersChildren's Hospital & Research Center Oakland, Oakland, NY, USA.
Joseph LipscombHealth Policy and Management, Rollins School of Public Health, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Wael SaberCIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA wsaber@mcw.edu.
Prakash SatwaniDivision of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, Columbia University Medical Center, New York, NY, USA.
Medical College of Wisconsin · USColumbia University Irving Medical Center · USEmory University Hospital · USNationwide Children's Hospital · USRainbow Babies & Children's Hospital · USUniversity of Pennsylvania · USBaylor College of Medicine · USChildren's Hospital of Orange County · USChildren's National · USCHRISTUS Transplant Institute · USCincinnati Children's Hospital Medical Center · USCleveland Clinic · USColumbia University · USDuke Medical Center · USEmory University · USHospital Infantil Universitario Niño Jesús · ESKing Faisal Specialist Hospital & Research Centre · SALevine Children's Hospital · USLouisiana State University · USMayo Clinic in Arizona · US
Funding
Data Resource for Analyzing Blood &Marrow TransplantsU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · 1998 to 2026
$105.2MEasy-to-read Informed Consent for HCT Clinical TrialsU10HL069294 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI HOROWITZ, MARY MARESCA · 2011 to 2016
$43.8MNCI NIH HHS U24 CA076518NHLBI NIH HHS U10 HL069294
Abstract
Advances in allogeneic hematopoietic cell transplantation for sickle cell disease have improved outcomes, but there is limited analysis of healthcare utilization in this setting. We hypothesized that, compared to late transplantation, early transplantation (at age <10 years) improves outcomes
Indexed as
Hematopoietic Stem Cell TransplantationPatient Acceptance of Health CareAdolescentAnemia, Sickle CellBone Marrow TransplantationChildChild, PreschoolClinical Decision-MakingComorbidityDatabases, FactualFemaleGraft vs Host DiseaseHealth Care CostsHumansIncidenceInfant
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.